-
Innovation Ranking
NewInnovation Ranking – La Jolla Pharmaceutical Company
La Jolla Pharmaceutical Company (La Jolla) discovers, develops and commercializes biopharmaceutical products for life-threatening diseases. The company’s major product includes the US FDA approved Giapreza, an injection for intravenous infusion indicated to increase blood pressure in adults with septic or other distributive shock and Xerava (eravacycline), is an injection of tetracycline class antibacterial for the treatment of complicated intra-abdominal infections (cIAI) in adults. Its investigational product candidates include LJPC-0118 intended for the treatment of severe malaria and LJPC-401, a proprietary...
-
Innovation Ranking
NewInnovation Ranking – La-Z-Boy Inc
La-Z-Boy Inc (La-Z-Boy) is a furniture company that manufactures, markets, imports, distributes, and retails upholstery products, accessories, and case goods furniture related products. La-Z-Boy markets its products under La-Z-Boy, Kincaid, American Drew and Hammary brand names. The comapany sells its products through a network of La-Z-Boy Furniture Galleries stores, Comfort Studios and other dealers. Its product portfolio includes recliners and motion furniture, sofas, loveseats, chairs, ottomans, sleepers, sectionals, tables, entertainment centers, bedroom sets, dining room sets and accent pieces. It...
-
Innovation Ranking
NewInnovation Ranking – La Francaise Des Jeux SA
La Francaise Des Jeux SA (FDJ), owned and operated by the French government, is a lottery and sports betting game operator. The company offers flash games, drawing games, eSport, and sport bets. Its draw games include Euro Millions-My Million, Joker+, Loto, Keno Gagnant a vie, and Amigo. Francaise Des Jeux operates two sports betting, of which one is distributed under exclusive rights through its retail network (ParionsSport Point de Vente), and another one is a competitive offering distributed over the...
-
Innovation Ranking
NewInnovation Ranking – F. Hoffmann-La Roche Ltd
F. Hoffmann-La Roche Ltd (Roche) is a biotechnology company that develops drugs and diagnostics to treat major diseases. It provides medicines for the treatment of cancer, other auto-immune diseases, central nervous system disorders, ophthalmological disorders, infectious diseases, and respiratory diseases. The company also offers in vitro diagnostics, tissue-based cancer diagnostics, and diabetes management solutions. Roche conducts research to identify novel methods to prevent, diagnose, and treat diseases. The company offers its products and services to hospitals, healthcare professionals, commercial laboratories,...
-
Product Insights
NewNet Present Value Model: F. Hoffmann-La Roche Ltd’s Ruzotolimod
Empower your strategies with our Net Present Value Model: F. Hoffmann-La Roche Ltd's Ruzotolimod report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: F. Hoffmann-La Roche Ltd’s Ipatasertib
Empower your strategies with our Net Present Value Model: F. Hoffmann-La Roche Ltd's Ipatasertib report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: F. Hoffmann-La Roche Ltd’s Trontinemab
Empower your strategies with our Net Present Value Model: F. Hoffmann-La Roche Ltd's Trontinemab report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: F. Hoffmann-La Roche Ltd’s Tobemstomig
Empower your strategies with our Net Present Value Model: F. Hoffmann-La Roche Ltd's Tobemstomig report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: F. Hoffmann-La Roche Ltd’s Astegolimab
Empower your strategies with our Net Present Value Model: F. Hoffmann-La Roche Ltd's Astegolimab report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: F. Hoffmann-La Roche Ltd’s Vixarelimab
Empower your strategies with our Net Present Value Model: F. Hoffmann-La Roche Ltd's Vixarelimab report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.